New demyelination mechanism in MS
New study reveals how dysregulated copper metabolism may cause demyelination in multiple sclerosis
MOREEC approval for Libmeldy
Developed thanks to more than 15 years of research by the San Raffaele Telethon Institute for Gene Therapy in Milan, Libmeldy is the first therapy approved for eligible patients with early-onset MLD
MOREEffective antibodies against SARS-CoV-2
Discovered a group of antibodies associated with reduced mortality in Covid-19 patients
MOREHighlights
Unmasking cancer cells
A synthetic molecule developed at San Raffaele could help make tumors more visible to the...
A new strategy to monitor gene therapy long-term safety and efficacy
Researchers at San Raffaele developed a new technique, allowing to probe cell free-DNA...
Scientists discover a new regulator of antiviral and antitumor immunity
Researchers at SR-Tiget identified a novel mechanism responsible for regulating innate...
Research Highlights
Great research leads to great results. Our pioneering science in numbers.
Research integrity
Upholding high standards of quality, trustworthiness and reproducibility
Industry collaborations
Join the excellence. Explore our integrated biomedical innovation pipeline.
Science outreach
Bridging the gap between science and society, for the benefit of both.